Mangalam Cost Of Revenue from 2010 to 2025
| MANGALAM | 103.56 2.54 2.51% |
Cost Of Revenue | First Reported 2011-12-31 | Previous Quarter 404.1 M | Current Value 406.6 M | Quarterly Volatility 188.7 M |
Check Mangalam Drugs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mangalam Drugs' main balance sheet or income statement drivers, such as Depreciation And Amortization of 176.9 M, Interest Expense of 168 M or Selling General Administrative of 471.8 M, as well as many indicators such as . Mangalam financial statements analysis is a perfect complement when working with Mangalam Drugs Valuation or Volatility modules.
Mangalam | Cost Of Revenue |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Mangalam Stock
Mangalam Drugs financial ratios help investors to determine whether Mangalam Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mangalam with respect to the benefits of owning Mangalam Drugs security.